ARTICLES BY THIS AUTHOR
- 7/21/2021
Slayback names Pete Meyers CFO
Meyers most recently served as CFO of Eagle Pharmaceuticals. - 7/23/2021
Intas, Meiji and Dong-A ST to commercialize Stelara biosimilar
Biosimilar ustekinumab will provide a treatment of autoimmune and inflammatory diseases such as plaque psoriasis, Crohn's disease and ulcerative colitis. - 7/27/2021
FDA tentatively OKs Zydus Cadila’s generic Imbruvica
Zydus Cadila's generic Imbruvica tablets provide a treatment for certain types of cancer. - 7/27/2021
Rolling with the punches: Generics firms innovate, expand scope to stay competitive
As they continue to navigate pandemic headwinds, generics firms look to broaden their portfolios and vertically integrate to keep competitive. - 7/28/2021
Merck obtains FDA OK for new indication of Keytruda
Keytruda is now approved for 30 indications. - 7/27/2021
Hy-Vee to host COVID-19 vaccination clinics during Iowa State Fair
Individuals can receive a $10 Hy-Vee gift card for completing a COVID-19 vaccine. - 7/27/2021
GSK starts shipping influenza vaccines for 2021-2022 season
GSK said it expects to distribute a record supply of more than 50 million doses of its influenza vaccine for the upcoming flu season. - 7/27/2021
Optum Frontier Therapies debuts in Las Vegas
Optum Frontier Therapies' flagship location will serve rare disease patients in all 50 states. - 7/26/2021
Omnicell to acquire FDS Amplicare for $177M
The FDS Amplicare business that is being acquired had roughly $29 million of total revenue for the 12 months ended June 30. - 7/27/2021
FDA approves new Shingrix indication
Shingrix is now approved for the prevention of shingles in those who are immunocompromised.